Welcome to LookChem.com Sign In|Join Free
  • or
3-(4-methoxybenzyl)-5,5-dimethylimidazolidine-2,4-dione is a complex organic compound with the molecular formula C12H15NO4. It is a derivative of imidazolidine-2,4-dione, featuring a 4-methoxybenzyl group attached to the 3-position of the imidazolidine ring. 3-(4-methoxybenzyl)-5,5-dimethylimidazolidine-2,4-dione is known for its potential applications in pharmaceuticals and chemical research, particularly in the synthesis of various biologically active molecules. Its structure provides a unique combination of aromatic, aliphatic, and heterocyclic moieties, which can contribute to its reactivity and stability in different chemical environments. The compound's properties, such as solubility and reactivity, can be influenced by the presence of the methoxy group, which can also affect its potential interactions with other molecules in biological systems.

220615-80-5

Post Buying Request

220615-80-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

220615-80-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 220615-80-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,0,6,1 and 5 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 220615-80:
(8*2)+(7*2)+(6*0)+(5*6)+(4*1)+(3*5)+(2*8)+(1*0)=95
95 % 10 = 5
So 220615-80-5 is a valid CAS Registry Number.

220615-80-5Relevant academic research and scientific papers

IMIDAZOLIDIN-2-ONE COMPOUNDS AS PRMT5 MODULATORS

-

Page/Page column 101, (2019/10/15)

The present invention relates to the derivatives of compound of formula (I) and pharmaceutically acceptable salts thereof. The present invention further provides the methods of preparation of compound of formula (I) and use thereof as PRMT5 inhibitors. Th

CYCLIC UREA- OR LACTAM-SUBSTITUTED QUINOXALINE-TYPE PIPERIDINE COMPOUNDS AND THE USES THEREOF

-

Page/Page column 321-322, (2014/02/16)

The disclosure relates to Cyclic Urea- or Lactam-Substituted Quinoxaline-Type Piperidine Compounds of Formula (I): and pharmaceutically acceptable derivatives thereof wherein R1, R2, Qa, Y1, Z, A, B, Qx, E, G, J, M, U, W, and a are as defined herein, compositions comprising an effective amount of a Cyclic Urea- or Lactam-Substituted Quinoxal ine-Type Piperidine Compound, and methods to treat or prevent a condition, such as pain, comprising administering to an animal in need thereof an effective amount of a Cyclic Urea- or Lactam-Substituted Quinoxaline-Type Piperidine Compound.

NOVEL AMIDE DERIVATIVE AND USE THEREOF AS MEDICINE

-

Paragraph 0297; 0298; 0299, (2013/03/26)

Provided are a novel low-molecular-weight compound that suppresses production of induction type MMPs, particularly MMP-9, rather than production of hemostatic type MMP-2, as well as a prophylactic/therapeutic drug for autoimmune diseases or osteoarthritis. An amide derivative represented by the following formula (I) wherein each symbol is as defined in the specification, or a pharmacologically acceptable salt thereof.

Substituted imidazoline-2,4-diones, process for preparation thereof, medicaments comprising these compounds and use thereof

-

Page/Page column 82, (2011/05/16)

The invention relates to compounds of formula (I) wherein the groups R and R′, A, D, E, G, L, p and R1 to R10 have the stated meanings and to their physiologically compatible salts. Said compounds are suitable, for example, as anti-obesity drugs.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 220615-80-5